News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
313,567 Results
Type
Article (13939)
Company Profile (32)
Press Release (299596)
Multimedia
Podcasts (20)
Webinars (8)
Section
Business (95594)
Career Advice (634)
Deals (19319)
Drug Delivery (66)
Drug Development (42789)
Employer Resources (52)
FDA (7724)
Job Trends (6848)
News (167094)
Policy (15809)
Tag
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2026 Genetown Elite (1)
Academia (874)
Accelerated approval (3)
Adcomms (8)
Allergies (42)
Alliances (19800)
ALS (44)
Alzheimer's disease (765)
Antibody-drug conjugate (ADC) (54)
Approvals (7755)
Artificial intelligence (122)
Autoimmune disease (16)
Automation (5)
Bankruptcy (195)
Best Places to Work (6062)
BIOSECURE Act (7)
Biosimilars (35)
Biotechnology (27)
Bladder cancer (51)
Brain cancer (16)
Breast cancer (149)
Cancer (1317)
Cardiovascular disease (88)
Career advice (553)
Career pathing (7)
CAR-T (95)
Cell therapy (258)
Cervical cancer (12)
Clinical research (35811)
Collaboration (393)
Compensation (139)
Complete response letters (10)
COVID-19 (1022)
CRISPR (20)
C-suite (139)
Cystic fibrosis (55)
Data (1442)
Denatured (3)
Depression (24)
Diabetes (151)
Diagnostics (3078)
Digital health (9)
Diversity (2)
Diversity, equity & inclusion (17)
Drug discovery (65)
Drug pricing (94)
Drug shortages (19)
Duchenne muscular dystrophy (59)
Earnings (44683)
Editorial (25)
Employer branding (3)
Employer resources (45)
Events (41999)
Executive appointments (461)
FDA (8488)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (386)
Gene editing (59)
Generative AI (10)
Gene therapy (169)
GLP-1 (304)
Government (1989)
Grass and pollen (2)
Guidances (39)
Healthcare (9155)
Huntington's disease (9)
IgA nephropathy (16)
Immunology and inflammation (52)
Indications (19)
Infectious disease (1097)
Inflammatory bowel disease (81)
Inflation Reduction Act (7)
Influenza (27)
Intellectual property (63)
Interviews (88)
IPO (9781)
IRA (44)
Job creations (1101)
Job search strategy (485)
Kidney cancer (8)
Labor market (11)
Layoffs (114)
Leadership (5)
Legal (3457)
Liver cancer (41)
Lung cancer (184)
Lymphoma (94)
Machine learning (1)
Management (15)
Manufacturing (149)
MASH (46)
Medical device (6513)
Medtech (6516)
Mergers & acquisitions (9946)
Metabolic disorders (377)
Multiple sclerosis (50)
NASH (10)
Neurodegenerative disease (39)
Neuropsychiatric disorders (12)
Neuroscience (1051)
NextGen: Class of 2025 (2724)
Non-profit (1480)
Northern California (1528)
Now hiring (5)
Obesity (189)
Opinion (124)
Ovarian cancer (55)
Pain (46)
Pancreatic cancer (50)
Parkinson's disease (85)
Partnered (7)
Patents (151)
Patient recruitment (69)
Peanut (23)
People (28829)
Pharmaceutical (19)
Pharmacy benefit managers (12)
Phase I (11371)
Phase II (15871)
Phase III (11965)
Pipeline (832)
Policy (95)
Postmarket research (973)
Preclinical (4204)
Press Release (23)
Prostate cancer (62)
Psychedelics (16)
Radiopharmaceuticals (156)
Rare diseases (213)
Real estate (1696)
Recruiting (21)
Regulatory (11503)
Reports (19)
Research institute (817)
Resumes & cover letters (80)
Rett syndrome (3)
RNA editing (2)
RSV (23)
Schizophrenia (42)
Series A (76)
Series B (39)
Service/supplier (2)
Sickle cell disease (36)
Southern California (1304)
Special edition (9)
Spinal muscular atrophy (46)
Sponsored (20)
Startups (1358)
State (1)
Stomach cancer (6)
Supply chain (37)
Tariffs (10)
The Weekly (15)
United States (13137)
Vaccines (268)
Venture capitalists (13)
Weight loss (122)
Women's health (14)
Worklife (7)
Date
Today (82)
Last 7 days (330)
Last 30 days (1455)
Last 365 days (19728)
2025 (5768)
2024 (21216)
2023 (23334)
2022 (28580)
2021 (30347)
2020 (28727)
2019 (21466)
2018 (16203)
2017 (15458)
2016 (13675)
2015 (16366)
2014 (11741)
2013 (9004)
2012 (9424)
2011 (9997)
2010 (9174)
Location
Africa (273)
Alabama (21)
Alaska (3)
Arizona (80)
Arkansas (7)
Asia (21906)
Australia (5216)
California (3437)
Canada (1328)
China (287)
Colorado (168)
Connecticut (177)
Delaware (71)
Europe (39454)
Florida (512)
Georgia (114)
Idaho (12)
Illinois (288)
India (22)
Indiana (183)
Japan (101)
Kansas (23)
Kentucky (8)
Louisiana (5)
Maine (38)
Maryland (463)
Massachusetts (2596)
Michigan (91)
Minnesota (160)
Missouri (54)
Montana (22)
Nebraska (10)
Nevada (44)
New Hampshire (47)
New Jersey (1166)
New Mexico (10)
New York (1029)
North Carolina (528)
North Dakota (2)
Northern California (1528)
Ohio (99)
Oklahoma (6)
Oregon (10)
Pennsylvania (824)
Puerto Rico (7)
Rhode Island (16)
South America (473)
South Carolina (11)
Southern California (1304)
Tennessee (53)
Texas (529)
Utah (98)
Virginia (91)
Washington D.C. (28)
Washington State (379)
West Virginia (2)
Wisconsin (22)
313,567 Results for "cytopia limited formerly medica holdings limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering
April 14, 2025
·
5 min read
Press Releases
Health Canada approves IMFINZI® (durvalumab) as the first and only immunotherapy regimen for adult patients with limited-stage small cell lung cancer (LS-SCLC)
April 10, 2025
·
6 min read
Press Releases
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering
January 8, 2025
·
4 min read
Press Releases
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option
January 14, 2025
·
4 min read
Press Releases
Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering
January 16, 2025
·
5 min read
Press Releases
Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering
January 14, 2025
·
5 min read
Qilian International Holding Group Limited Announces 1 for 5 Reverse Share Split
Qilian International Holding Group Limited, a China-based pharmaceutical and chemical products manufacturer, announced that an 1 for 5 reverse split of its authorized share capital, was approved by the Company’s board of directors on May 29, 2023 and will become effective on June 21, 2024.
June 18, 2024
·
4 min read
Press Releases
Dynavax Adopts Limited-Duration Stockholder Rights Plan
October 30, 2024
·
5 min read
Press Releases
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization
April 7, 2025
·
4 min read
Press Releases
Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement
March 13, 2025
·
3 min read
1 of 31,357
Next
